Roche, Gilead top patient groups’ rankings of pharma ESG practices
Despite falling business interest in environmental, social and governance policies and outright opposition to such sustainability and ethics commitments in the U.S., company ESG practices still matter to patient groups’ perceptions of Big Pharma.
Despite falling business interest in environmental, social and governance policies and outright opposition to such sustainability and ethics commitments in the U.S., company ESG practices still matter to patient groups’ perceptions of Big Pharma.
